Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic
about
Beta-blockers for prevention of oesophageal variceal rebleeding in cirrhotic patientsPrimary prophylaxis of bleeding from esophageal varices in cirrhosisRepurposing of approved cardiovascular drugsSystematic review with meta-analysis: the association between the use of calcium channel blockers and gastrointestinal bleedingDrug therapy for portal hypertensionEndoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trialPrevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)Preventive care in chronic liver disease.Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosis.Oesophageal varices: assessment of the risk of bleeding and mortality.Hospitalization for variceal hemorrhage in an era with more prevalent cirrhosis.Modern management of oesophageal varices.Review article: a drug therapy for the prevention of variceal haemorrhage.Future therapy of portal hypertension in liver cirrhosis - a guess.The effect of propranolol in malay patients with liver cirrhosis - a pharmacodynamic evaluation.Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis.Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.Improving prognosis following a first variceal haemorrhage over four decadesEvaluation of carvedilol for the treatment of portal hypertension.Risk of liver cancer among US male veterans with cirrhosis, 1969-1996Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis.Hemodynamic effects of propranolol with spironolactone in patients with variceal bleeds: a randomized controlled trial.A fourfold increase of oesophageal variceal bleeding in cirrhotic patients with a history of oesophageal variceal bleeding.Variceal bleeding : pharmacological treatment and prophylactic strategies.Medical Care of the Patient With Compensated Cirrhosis.Overview of the methods and therapies for the primary prevention of variceal bleeding.Primary prevention of variceal hemorrhage.Management of varices in cirrhosis.Management of varices in patients with cirrhosis.Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis.Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature.Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials.Role of endoscopy in management of gastrointestinal complications of portal hypertension.Is it time to replace propranolol with carvedilol for portal hypertension?Beta-blockers in patients with advanced liver disease: Has the dust settled?Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices.Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.Prevention and treatment of variceal haemorrhage in 2017.Nonselective β-blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients.Complications of cirrhosis. Why they occur and what to do about them.
P2860
Q24244763-BC76E44D-3C0C-473E-9B3F-19A7598DBDBAQ27011637-3A9F3558-675F-40AD-A9C0-BE20FD310982Q28074453-5A9BB6CA-925F-4D32-A1C0-24F216CA5C22Q28081521-D34EFA48-6A93-4372-9FBC-DD951304D10BQ28346284-6F199D74-CE05-487E-97B2-C43C41780839Q28373295-4666CF92-8C7C-481A-AF84-4E7F78FBB250Q33562288-C8660B8B-0BDA-4339-85BA-9C8F4CABA5B8Q33778884-7CA962DC-4183-4F06-90B2-A4F057C3FDBFQ33961964-601FCC6C-9C28-48E4-8946-CBC80E30A29FQ34055839-1D6CDF94-5AF4-4D86-84B5-B464FFD8965EQ34093871-971F43DA-EA88-4962-B18C-304375665237Q34132054-59C53C2B-AEA0-42E5-A5AF-149F993E8C80Q34156200-36E081F3-E2B5-450C-A987-E69B62BDE7A1Q34446521-9AD19F0C-80FA-4E1C-B428-BD3552EABEB0Q34568131-78DDDC5E-E973-4CF4-BF81-6382A33B11D4Q35169410-957C3A31-16F6-41DF-9CCF-0AE62254E098Q35349306-D7C216FE-4717-4A7F-95E7-61A150FE147CQ35365599-4ABA6CA1-3E6C-460F-B1FD-31048D887046Q35637082-3A4280F4-EB03-4108-9F8E-9403D2EC5B3EQ36075198-C58003FD-AF9D-4AAF-942F-2A8BED7723D1Q36854110-7B2F64AA-05D6-468F-ABA6-24023B3C0558Q37237710-75478D0A-CC0E-4116-8A3E-948A92D8D319Q37264052-46AE98D2-C1F6-4539-885E-D384FA82D12DQ37313406-B0757780-4ED9-46C9-87FA-7E02895D6EB8Q37678908-74E9AD69-5BEE-4EF3-854B-13565DA5BCA5Q37777150-6047DCA0-6CC3-45B9-9B2E-C335A6AD2BC9Q37810525-49530C83-7B92-4FAB-ACEE-1FEFFC260481Q37832507-ECCE30CD-9FC7-4DFB-8B86-8C33332D5723Q38094881-04E96BFD-E5E4-4390-B432-10C5EA0F0A48Q38229031-8E5F75BA-C98D-4CBE-BFE2-972FE60D6178Q38239061-8BCE9AEA-7219-4715-B416-5A8FF22FF6CEQ38315552-F10B4291-3089-4A9B-8866-FD28C8D44410Q38327883-03E2059F-7A20-4F35-AFB6-326373ABFB9CQ38493078-0877B46C-7190-40FD-91B7-18AF2E36DC4AQ38673738-0E2C6EBA-1C21-4DFA-A88E-49EAEC571B40Q38770583-5C38339B-230D-4C83-90AE-6607F9CCC198Q38772074-6BDA89F0-1A3A-4310-A0BA-409516C77CB2Q39067320-E1458AE2-2A18-4554-B6DC-70857FB880CBQ40282684-941DC3C5-701C-444F-B024-7C36E8218FF6Q41710516-B98A8AA6-DFB8-49F2-9A00-DE36C59C6435
P2860
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Beta-adrenergic-antagonist dru ...... trials. Franco-Italian Multic
@ast
Beta-adrenergic-antagonist dru ...... trials. Franco-Italian Multic
@en
type
label
Beta-adrenergic-antagonist dru ...... trials. Franco-Italian Multic
@ast
Beta-adrenergic-antagonist dru ...... trials. Franco-Italian Multic
@en
prefLabel
Beta-adrenergic-antagonist dru ...... trials. Franco-Italian Multic
@ast
Beta-adrenergic-antagonist dru ...... trials. Franco-Italian Multic
@en
P2093
P1476
Beta-adrenergic-antagonist dru ...... trials. Franco-Italian Multic
@en
P2093
P304
P356
10.1056/NEJM199105303242202
P407
P577
1991-05-01T00:00:00Z